Comparison of sunitinib (su) versus temsirolimus (tem) in patients (pts) with poor risk metastatic renal cell carcinoma (prmRCC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Victoria Neiman, Daniel Keizman, Avishay Sella, Eli Rosenbaum, Maya Gottfried, Natalie Maimon, David Sarid, Eli Gez, Michael Anthony Carducci, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Avivit Peer, Avivit Neumann, Svetlana Kovel, Wilmosh Mermershtain, Keren Rouvinov, Ilan Feldhamer, Raanan Berger, Ariel Hammerman
Institutions: Tel Aviv University, Rabin Medical Center, Meir Medical Center, Assaf Harofeh Medical Center, Tel Aviv Sourasky Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Rambam Health Care Campus, Soroka Medical Center, Clalit Health Services, Sheba Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4243398323